Invesco
INDV icon

Invesco’s Indivior Pharmaceuticals INDV Stock Holding History

Invesco’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.6M Buy
1,561,763
+1,275,074
+445% +$42.1M ﹤0.01% 1092
2025
Q4 		$10.3M Buy
286,689
+210,150
+275% +$6.42M ﹤0.01% 1821
2025
Q3 		$1.85M Buy
+76,539
New +$1.6M ﹤0.01% 2646

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco's INDV Position: Q1 2026 in Review

Invesco increased its Indivior Pharmaceuticals (INDV) stake by 445% in Q1 2026, buying an estimated $42.1M and bringing the position to 1,561,763 shares worth $47.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Invesco first reported a position in INDV in Q3 2025 and has held it in 3 quarters since. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Invesco held 1,561,763 shares of Indivior Pharmaceuticals worth $47.6M as of Q1 2026.
  • Invesco bought 1,275,074 Indivior Pharmaceuticals shares in Q1 2026, an estimated $42.1M.
  • Indivior Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #1092 holding.
  • Invesco first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.